Novartis CEO Joseph Jimenez Pushes Drug Discovery
When Joseph Jiminez took over as Novartis CEO he invested heavily in R&D and expanded into emerging markets. He speaks to Institutional Investor Senior Writer Julie Segal.
Julie Segal
February 15, 2012